DataMeds AI annual revenue
2022
2023
2024
2025
DataMeds AI reported $23.3M in revenue for fiscal 2025, an increase of 28.73% from the previous fiscal year.
View full DataMeds AI company overview| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $23.3M | $5.2M | +28.73% |
| 2024 | 2024-12-31 | $18.1M | $18.1M | — |
| 2023 | 2023-12-31 | $0 | −$32.8M | −100.00% |
| 2022 | 2022-12-31 | $32.8M | — | — |
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.8M | −$6.0M | −77.15% |
| Q1 2026 | 2026-03-31 | $1.6M | −$9.3M | −85.64% |
| Q4 2025 | 2025-12-31 | $1.7M | — | — |
| Q3 2025 | 2025-09-30 | $3.0M | −$2.7M | −46.90% |
| Q2 2025 | 2025-06-30 | $7.8M | $7.7M | +17391.84% |
| Q1 2025 | 2025-03-31 | $10.9M | — | — |
| Q3 2024 | 2024-09-30 | $5.7M | — | — |
| Q2 2024 | 2024-06-30 | $44,540 | — | — |
DataMeds AI's latest reported quarter, Q2 2026, generated $1.8M in revenue, a decrease of 77.15% year over year.
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review DataMeds AI source filings ↗